Sanofi India Limited (SANOFI.NS) NSE
3,251.40
+15.6(+0.48%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
3,251.40
+15.6(+0.48%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1225
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Mahadev Gawade | Additional Whole-time Director & Site Head - Goa | 6.41M | N/A |
| Deepak Arora | Country Lead, MD & GM of Pharma | 8.23M | N/A |
| Rachid Ayari | Chief Financial Officer & Whole Time Director | 22M | 1975 |
| Bratin Bag | Senior Director of Ethics & Business Integrity, South Asia | 0 | N/A |
| Haresh Bachubhai Vala | Company Secretary & Compliance Officer | 0 | N/A |
| K. Narayanaswamy | Senior Director of Accounting & Taxation | 0 | 1955 |
| Nakul Verma | Senior Director of Public Affairs and Head of Public Affairs & Market Access | 0 | N/A |
| Sanjay V. Chavan | Head of Country Procurement - India | 0 | 1962 |
| Nitya Padmanabhan | Head of Vaccines for Sanofi Healthcare India Private Limited | 0 | N/A |
| Sudipta Chakraborty | Head of Legal & Whole-time Director | 0 | 1982 |
| Aniket Raje | Head of Regulatory Affairs | 0 | N/A |
| Richa Bakshi | Head of People Excellence | 0 | N/A |
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.